Efficacy and Safety of Linagliptin in Subjects With Long-Standing Type 2 Diabetes Mellitus >10 Years: Evidence From Pooled Data of Randomized, Double-Blind, Placebo-Controlled, Phase III Trials – Clinical Therapeutics

Efficacy and Safety of Linagliptin in Subjects With Long-Standing Type 2 Diabetes Mellitus >10 Years: Evidence From Pooled Data of Randomized, Double-Blind, Placebo-Controlled, Phase III Trials – Clinical Therapeutics.

Leave a comment